Clinical Trial Update: A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of inebilizumab in IgG4-related disease, with results posted and the study listed as active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Igg4-related Disease

Drugs mentioned

• Inebilizumab (inebilizumab)

Snippet

Sponsor: Amgen | Conditions: IgG4 Related Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-06-25